PIK3CA and cancer: Consistently, data from the Cancer Cell Line Encyclopedia (CCLE) and Domcke et al. [36] revealed activating mutations and amplifications in PIK3CA in serous, clear-cell, mucinous, and mixed subtype OvCa cell lines, including cell lines that have been extensively used in preclinical models of OvCa (Table 1).